Logo image of AQNB

ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079 (AQNB) Stock Fundamental Analysis

NYSE:AQNB - New York Stock Exchange, Inc. - US0158578080 - Currency: USD

25.65  -0.01 (-0.04%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AQNB. AQNB was compared to 25 industry peers in the Multi-Utilities industry. AQNB may be in some trouble as it scores bad on both profitability and health. AQNB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year AQNB was profitable.
AQNB had a positive operating cash flow in the past year.
Of the past 5 years AQNB 4 years were profitable.
Each year in the past 5 years AQNB had a positive operating cash flow.
AQNB Yearly Net Income VS EBIT VS OCF VS FCFAQNB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M -1B

1.2 Ratios

The Return On Assets of AQNB (-6.24%) is worse than 96.00% of its industry peers.
AQNB has a Return On Equity of -22.90%. This is amonst the worse of the industry: AQNB underperforms 96.00% of its industry peers.
AQNB has a Return On Invested Capital of 2.91%. This is amonst the worse of the industry: AQNB underperforms 88.00% of its industry peers.
AQNB had an Average Return On Invested Capital over the past 3 years of 2.30%. This is in line with the industry average of 3.68%.
The last Return On Invested Capital (2.91%) for AQNB is above the 3 year average (2.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -6.24%
ROE -22.9%
ROIC 2.91%
ROA(3y)0.13%
ROA(5y)2.2%
ROE(3y)0.18%
ROE(5y)5.78%
ROIC(3y)2.3%
ROIC(5y)2.45%
AQNB Yearly ROA, ROE, ROICAQNB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10

1.3 Margins

AQNB's Profit Margin has declined in the last couple of years.
AQNB's Operating Margin of 19.49% is on the low side compared to the rest of the industry. AQNB is outperformed by 68.00% of its industry peers.
In the last couple of years the Operating Margin of AQNB has declined.
AQNB has a better Gross Margin (74.55%) than 76.00% of its industry peers.
AQNB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.49%
PM (TTM) N/A
GM 74.55%
OM growth 3Y-6.79%
OM growth 5Y-4.27%
PM growth 3Y-74.64%
PM growth 5Y-41.23%
GM growth 3Y-1.6%
GM growth 5Y0.32%
AQNB Yearly Profit, Operating, Gross MarginsAQNB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AQNB is destroying value.
The number of shares outstanding for AQNB has been increased compared to 1 year ago.
Compared to 5 years ago, AQNB has more shares outstanding
AQNB has a worse debt/assets ratio than last year.
AQNB Yearly Shares OutstandingAQNB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
AQNB Yearly Total Debt VS Total AssetsAQNB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 0.98, we must say that AQNB is in the distress zone and has some risk of bankruptcy.
AQNB has a Altman-Z score of 0.98. This is amongst the best in the industry. AQNB outperforms 84.00% of its industry peers.
AQNB has a Debt/Equity ratio of 1.49. This is a high value indicating a heavy dependency on external financing.
AQNB has a Debt to Equity ratio (1.49) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF N/A
Altman-Z 0.98
ROIC/WACC0.44
WACC6.6%
AQNB Yearly LT Debt VS Equity VS FCFAQNB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B

2.3 Liquidity

AQNB has a Current Ratio of 0.92. This is a bad value and indicates that AQNB is not financially healthy enough and could expect problems in meeting its short term obligations.
AQNB has a Current ratio of 0.92. This is in the better half of the industry: AQNB outperforms 80.00% of its industry peers.
AQNB has a Quick Ratio of 0.92. This is a bad value and indicates that AQNB is not financially healthy enough and could expect problems in meeting its short term obligations.
AQNB's Quick ratio of 0.77 is fine compared to the rest of the industry. AQNB outperforms 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.77
AQNB Yearly Current Assets VS Current LiabilitesAQNB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

3

3. Growth

3.1 Past

The earnings per share for AQNB have decreased strongly by -18.97% in the last year.
AQNB shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.95% yearly.
AQNB shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.32%.
Measured over the past years, AQNB shows a quite strong growth in Revenue. The Revenue has been growing by 10.35% on average per year.
EPS 1Y (TTM)-18.97%
EPS 3Y-6.69%
EPS 5Y-4.95%
EPS Q2Q%-27.27%
Revenue 1Y (TTM)13.32%
Revenue growth 3Y17.17%
Revenue growth 5Y10.35%
Sales Q2Q%-8.24%

3.2 Future

The Earnings Per Share is expected to decrease by -4.45% on average over the next years.
The Revenue is expected to decrease by -0.28% on average over the next years.
EPS Next Y-22.74%
EPS Next 2Y-22.56%
EPS Next 3Y-11.12%
EPS Next 5Y-4.45%
Revenue Next Year-4.55%
Revenue Next 2Y-4.88%
Revenue Next 3Y-2.07%
Revenue Next 5Y-0.28%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AQNB Yearly Revenue VS EstimatesAQNB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AQNB Yearly EPS VS EstimatesAQNB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 54.57, the valuation of AQNB can be described as expensive.
Based on the Price/Earnings ratio, AQNB is valued more expensive than 92.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of AQNB to the average of the S&P500 Index (29.63), we can say AQNB is valued expensively.
A Price/Forward Earnings ratio of 82.25 indicates a quite expensive valuation of AQNB.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AQNB indicates a rather expensive valuation: AQNB more expensive than 96.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of AQNB to the average of the S&P500 Index (22.68), we can say AQNB is valued expensively.
Industry RankSector Rank
PE 54.57
Fwd PE 82.25
AQNB Price Earnings VS Forward Price EarningsAQNB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AQNB indicates a rather expensive valuation: AQNB more expensive than 96.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.4
AQNB Per share dataAQNB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A cheap valuation may be justified as AQNB's earnings are expected to decrease with -11.12% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-22.56%
EPS Next 3Y-11.12%

5

5. Dividend

5.1 Amount

AQNB has a Yearly Dividend Yield of 5.29%, which is a nice return.
Compared to an average industry Dividend Yield of 3.76, AQNB pays a better dividend. On top of this AQNB pays more dividend than 96.00% of the companies listed in the same industry.
AQNB's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 5.29%

5.2 History

The dividend of AQNB has a limited annual growth rate of 4.94%.
AQNB has been paying a dividend for over 5 years, so it has already some track record.
AQNB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)4.94%
Div Incr Years1
Div Non Decr Years4
AQNB Yearly Dividends per shareAQNB Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of AQNB are negative and hence is the payout ratio. AQNB will probably not be able to sustain this dividend level.
DP-28.84%
EPS Next 2Y-22.56%
EPS Next 3Y-11.12%
AQNB Yearly Income VS Free CF VS DividendAQNB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M -1B

25.65

-0.01 (-0.04%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)03-07 2025-03-07/amc
Inst Owners65.03%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap19.68B
Analysts68.57
Price Target23.64 (-7.84%)
Short Float %0%
Short Ratio0.47
Dividend
Industry RankSector Rank
Dividend Yield 5.29%
Yearly Dividend0.48
Dividend Growth(5Y)4.94%
DP-28.84%
Div Incr Years1
Div Non Decr Years4
Ex-Date03-14 2025-03-14 (0.5304)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.86%
Min EPS beat(2)-15.13%
Max EPS beat(2)13.41%
EPS beat(4)2
Avg EPS beat(4)-1.62%
Min EPS beat(4)-15.13%
Max EPS beat(4)13.41%
EPS beat(8)3
Avg EPS beat(8)-3.44%
EPS beat(12)4
Avg EPS beat(12)-5.16%
EPS beat(16)5
Avg EPS beat(16)-4.07%
Revenue beat(2)0
Avg Revenue beat(2)-2.63%
Min Revenue beat(2)-5.17%
Max Revenue beat(2)-0.08%
Revenue beat(4)1
Avg Revenue beat(4)-3.42%
Min Revenue beat(4)-9.57%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)-0.69%
Revenue beat(12)7
Avg Revenue beat(12)0.82%
Revenue beat(16)10
Avg Revenue beat(16)2.91%
PT rev (1m)0%
PT rev (3m)6.71%
EPS NQ rev (1m)3.23%
EPS NQ rev (3m)-44.56%
EPS NY rev (1m)2.52%
EPS NY rev (3m)-9.6%
Revenue NQ rev (1m)-12.03%
Revenue NQ rev (3m)-12.03%
Revenue NY rev (1m)2.6%
Revenue NY rev (3m)-0.33%
Valuation
Industry RankSector Rank
PE 54.57
Fwd PE 82.25
P/S 6.27
P/FCF N/A
P/OCF 31.03
P/B 4.06
P/tB 5.71
EV/EBITDA 24.4
EPS(TTM)0.47
EY1.83%
EPS(NY)0.31
Fwd EY1.22%
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)0.83
OCFY3.22%
SpS4.09
BVpS6.31
TBVpS4.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.24%
ROE -22.9%
ROCE 3.69%
ROIC 2.91%
ROICexc 2.92%
ROICexgc 3.19%
OM 19.49%
PM (TTM) N/A
GM 74.55%
FCFM N/A
ROA(3y)0.13%
ROA(5y)2.2%
ROE(3y)0.18%
ROE(5y)5.78%
ROIC(3y)2.3%
ROIC(5y)2.45%
ROICexc(3y)2.31%
ROICexc(5y)2.46%
ROICexgc(3y)2.53%
ROICexgc(5y)2.73%
ROCE(3y)2.91%
ROCE(5y)3.1%
ROICexcg growth 3Y-2.44%
ROICexcg growth 5Y-7.49%
ROICexc growth 3Y-1.59%
ROICexc growth 5Y-6.9%
OM growth 3Y-6.79%
OM growth 5Y-4.27%
PM growth 3Y-74.64%
PM growth 5Y-41.23%
GM growth 3Y-1.6%
GM growth 5Y0.32%
F-Score6
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF N/A
Debt/EBITDA 6.49
Cap/Depr 186.56%
Cap/Sales 29.67%
Interest Coverage 1.51
Cash Conversion 57.1%
Profit Quality N/A
Current Ratio 0.92
Quick Ratio 0.77
Altman-Z 0.98
F-Score6
WACC6.6%
ROIC/WACC0.44
Cap/Depr(3y)264.2%
Cap/Depr(5y)249.46%
Cap/Sales(3y)45.42%
Cap/Sales(5y)43.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.97%
EPS 3Y-6.69%
EPS 5Y-4.95%
EPS Q2Q%-27.27%
EPS Next Y-22.74%
EPS Next 2Y-22.56%
EPS Next 3Y-11.12%
EPS Next 5Y-4.45%
Revenue 1Y (TTM)13.32%
Revenue growth 3Y17.17%
Revenue growth 5Y10.35%
Sales Q2Q%-8.24%
Revenue Next Year-4.55%
Revenue Next 2Y-4.88%
Revenue Next 3Y-2.07%
Revenue Next 5Y-0.28%
EBIT growth 1Y21.37%
EBIT growth 3Y9.22%
EBIT growth 5Y5.64%
EBIT Next Year55.11%
EBIT Next 3Y12.57%
EBIT Next 5Y17.41%
FCF growth 1Y55.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.47%
OCF growth 3Y7.52%
OCF growth 5Y3.44%